The univariate survival analysis showed that OS was significantly associated with tumor stage (HR: 5.441, 95% CI: 2.687~11.020, P < 0.001), primary tumor site (HR: 0.880, 95% CI: 0.792~0.977, P = 0.016), palliative care (HR: 0.432, 95% CI: 0.328~0.569, P < 0.001), nutritional status (HR: 1.732, 95% CI: 1.336~2.246, P < 0.001), albumin level (HR: 0.943, 95% CI: 0.926~0.960, P < 0.001) and pretreatment NLR (HR: 1.377, 95% CI: 1.049~1.806, P = 0.020) (Table 3). The gene discussed is ALB; the disease is neoplasm.